Valuation: Bayer AG

Market Cap 48.39B 56.48B 45.35B 41.42B 78.17B 5,384B 78.94B 535B 208B 2,716B 212B 207B 8,996B P/E 2026 *
21x
P/E 2027 * 15.8x
Enterprise Value 78.24B 91.3B 73.31B 66.97B 126B 8,705B 128B 865B 337B 4,392B 343B 335B 14,544B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.08%
1 week+0.80%
Current month+1.92%
1 month+6.40%
3 months+27.59%
6 months+15.44%
Current year+32.71%
1 week 47.44
Extreme 47.445
49.92
1 month 45
Extreme 45
50.46
3 years 18.39
Extreme 18.39
53.9
5 years 18.39
Extreme 18.39
67.99
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+0.80%+74.75%-1.96% 56.48B
-1.63%-5.12%+65.05%+119.31% 1,100B
-0.86%-0.71%+53.81%+65.23% 658B
-1.28%-1.31%+25.98%+78.04% 470B
-1.40%+0.68%+42.71%+42.74% 372B
-0.79%+0.46%+26.09%+41.17% 304B
-2.04%+1.71%+3.23%+13.44% 264B
-0.50%-0.50%+52.00%+71.57% 239B
-0.93%+2.05%-12.92%-52.73% 213B
-0.11%+0.56%+29.34%+92.65% 184B
Average -1.06%+3.01%+36.00%+46.95% 422.54B
Weighted average by Cap. -1.21%+2.21%+42.27%+68.82%

Financials

2026 *2027 *
Net sales 45.75B 53.39B 42.87B 39.16B 73.91B 5,090B 74.64B 506B 197B 2,568B 200B 196B 8,505B 46.98B 54.82B 44.02B 40.21B 75.89B 5,227B 76.63B 519B 202B 2,637B 206B 201B 8,733B
Net income 2.14B 2.49B 2B 1.83B 3.45B 238B 3.49B 23.61B 9.19B 120B 9.36B 9.16B 397B 2.94B 3.43B 2.76B 2.52B 4.75B 327B 4.8B 32.51B 12.66B 165B 12.89B 12.61B 547B
Net Debt 29.84B 34.83B 27.97B 25.54B 48.21B 3,320B 48.68B 330B 128B 1,675B 131B 128B 5,548B 26.67B 31.12B 24.99B 22.82B 43.07B 2,967B 43.5B 295B 115B 1,497B 117B 114B 4,957B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
27/08/26 EUR 49.15 +0.11%
25/08/26 EUR 49.10 +1.25%
24/08/26 EUR 48.49 +1.44%
21/08/26 EUR 47.80 -1.54%
20/08/26 EUR 48.55 -1.18%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.26EUR
Average target price
56.83EUR
Spread / Average Target
+15.37%

Quarterly revenue - Rate of surprise